As billionaires race to fund anti-aging projects, a much-discussed trial goes overlooked
This story has been excerpted from the STAT Report “The race for longevity: How scientists…
Category: Biotech
Opinion: Addressing institutional trauma in health care: the case for a structured ethical framework
In recent years, many health care professionals have been confronting the challenging chapters of their…
Access to trauma care is improving across the country, but progress remains uneven
Six years ago, an expert panel made a strong suggestion to the White House: set…
Here’s who Democrats’ drug pricing bill will actually help
WASHINGTON — Millions of patients in the Medicare program could eventually see lower prescription drug costs…
Aldosterone, a hormone that prevents dehydration, is linked to worsening kidney disease, study suggests
A drug that has been used to slow progression of kidney and cardiovascular disease in…
STAT+: For the second time, Pfizer tries a drug warranty in response to concerns over high costs
For only the second time, Pfizer is offering a warranty for a medicine that will…
STAT+: The Senate’s drug pricing bill is an inevitable solution. It will still have plenty of unintended consequences
There’s really no ignoring the inexorable math that led the Senate to approve a plan…
A lobbying frenzy over surprise billing, employer dialysis questions, and a big broker throwdown
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow…
Study connects climate hazards to 58% of infectious diseases
Climate hazards such as flooding, heat waves, and drought have worsened more than half of…
STAT+: Pharmalittle: Medicare is poised to negotiate drug prices; Pfizer to pay $5.4 billion for Global Blood Therapeutics
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Karuna Therapeutics’ schizophrenia drug achieves study goals, heralding new treatment approach
Karuna Therapeutics said Monday that a novel combination pill reduced psychosis and related symptoms experienced…
Opinion: Triple-negative breast cancer highlights the need to act against health inequities
Deaths from breast cancer create huge holes in families and communities that cannot be filled….
STAT+: Telehealth fraud concerns, whether ‘overblown’ or not, could impact the industry’s future
Recent federal crackdowns on Medicare fraud linked to telehealth have raised concerns in Washington that…
STAT+: Health care industry swarms Washington as surprise billing rules get ironed out
Solving surprise medical bills was supposed to be straightforward. It has been anything but. Already,…
STAT+: At pioneering center for gene therapy, Jim Wilson presided over toxic, abusive workplace, staffers say
Scientist Jim Wilson is synonymous with gene therapy — and for good reason. For decades,…
In a massive victory for Democrats, Medicare is poised to negotiate drug prices
WASHINGTON — President Biden is on the verge of his own crowning health care achievement…
.jpg)
Democrats dramatically narrow their ambitions for lowering insulin costs
WASHINGTON — Democrats’ high hopes to lower insulin costs for patients with insurance got downsized on…
STAT+: Serious liver side effects detour Amgen’s effort to expand use of its KRAS-blocking lung cancer drug
A clinical trial run by Amgen that combined its KRAS-targeting cancer drug called Lumakras with…
Democrats will have to limit their drug pricing reforms to Medicare to comply with Senate rules
WASHINGTON — Democrats will likely have to axe two provisions from their drug pricing plan…
The glaring health equity gap in Democrats’ drug pricing plan
WASHINGTON — As Democrats close in on the biggest overhaul of the Medicare prescription drug…
A health equity expert on making monkeypox messaging more inclusive
The monkeypox outbreak that has spread around the world has disproportionately affected gay, bisexual, and…
Opinion: The U.S. must fully fund global polio eradication efforts
Reports that a man in his 20s in New York state contracted polio and detection…
STAT+: Pharmalittle: PhRMA threatens Dems if drug-pricing bill passes; Novo plays down worries over obesity drug supplies
And so, another working week will soon draw to a close. Not a moment too…
Opinion: The next generation of illicit drugs? Think ‘synthetic’
The illicit drug market continues to become more treacherous. Illicit drugs killed more than 107,000…
From the Navy to a neuroscience lab: how a daughter’s diagnosis spurred her mother’s career shift
Carina Block was working an overnight shift in the U.S. Navy base in Japan, guiding…
Nursing home chain’s tangled corporate structure and bankruptcy threats stymied litigation
After a hospital stay in 2016 for a brain tumor, Regina Romero was transferred to…
STAT+: From buzzy biomarkers to learning from failure: 3 takeaways from the Alzheimer’s Association International Conference
SAN DIEGO — From exploring new ways to spot the disease to rethinking what Alzheimer’s…
Polioviruses found in wastewater samples in 2 N.Y. counties, suggesting continued spread
New York State health authorities revealed Thursday that they had detected additional polioviruses in wastewater…
Listen: The last-minute push for drug pricing reform, Alnylam’s success, and Sarepta’s gamble
Is drug pricing reform really happening this time? Are things finally turning around for biotech?…
U.S. declares monkeypox outbreak a public health emergency
The Biden administration declared the ongoing monkeypox outbreak a public health emergency on Thursday, a…
New research digs into the genetic drivers of heart failure, with an eye to precision treatments
When coronary arteries are blocked, starving the heart of blood, there are good medications and…
STAT+: Pharmalittle: U.S. government blunder contributed to monkeypox vax shortage; Amgen to pay $4 billion for ChemoCentryx
Top of the morning to you. Another steamy day is unfolding here at the Pharmalot…
STAT+: Amgen to acquire ChemoCentryx for $4 billion, adding newly approved drug for autoimmune disorder
Amgen said Thursday that it will acquire the small drugmaker ChemoCentryx for $4 billion to…
Opinion: Are ‘modest’ drug price controls as bad for innovation as pharma claims?
Drug price controls proposed by Democrats in the U.S. Senate are being met with dire…
With monkeypox vaccine in high demand, NIH to test approaches to stretch supplies
As the monkeypox outbreak continues to grow, one thing seems abundantly clear. The global need…
Opinion: Addressing social drivers of health is a big opportunity for tech entrepreneurs
Some of the best business opportunities in health care will involve developing technologies that analyze…
Covid has settled into a persistent pattern — and remains damaging. It may not change anytime soon
Our tussle with Covid-19 — after a harrowing introduction and then wave upon wave of…
Patients seeking novel weight loss drugs find a ‘wild west’ of online prescribers
Briana Lawson was ready to knock her diabetes into remission. For years, the 47-year-old health…
STAT+: ‘How can you not be excited?’: AI experts share enthusiasm about its future in health care
While the adoption of artificial intelligence in health care has been slow and bumpy at…
STAT+: Lilly is ordered to pay $61 million for shortchanging the Medicaid drug rebate program
After nearly a decade of legal squabbling, Eli Lilly was ordered by a federal court…
Monoclonal antibody treatment for malaria shows encouraging results
An experimental antibody treatment prevented malaria in the majority of participants in a small but…
Red Cross beginning to screen blood donors for monkeypox
As monkeypox continues its relentless spread around the globe, organizations in the U.S. are taking…
STAT+: Civica Rx begins selling its first generic drug as it tries to overhaul the pharmaceutical supply chain
In the latest bid to address high prescription drug costs, a nonprofit plans to sell…
.jpg)
STAT+: Pharmalittle: AbbVie wins court opinion on Humira patent thickets; Alnylam heart disease drug succeeds in closely watched trial
Hello, everyone, and welcome to the middle of the week. You made it this far,…
Virtual Event: Creating AI That Improves Health
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET….
STAT+: Alnylam therapy for increasingly common heart disease succeeds in closely watched trial
Alnylam Pharmaceuticals’ treatment for an increasingly common heart disease succeeded in a closely watched clinical…
Opinion: Lack of diversity in clinical trials costs billions of dollars. Incentives can spur innovation
The lack of diversity in clinical trials unfairly skews American medicine and costs billions of…
Opinion: Inching closer to an essential global pandemic treaty
World Health Organization Director-General Tedros Adhanom Ghebreyesus recently declared monkeypox a public health emergency of…
The trust-builder: a cancer center director’s try-it-all strategy for breaking the barriers between research and Black patients
TRIALS AND TRUST: This is the second part of a series on health equity and…
STAT+: U.S. appeals court panel decides AbbVie’s ‘patent thickets’ for Humira don’t thwart competition
In a significant victory for AbbVie, a U.S. appeals court panel declined to revive a…